Revolutionising research: Inside the NCVR evolution in the UK

Join experts from the National Institute of Health and Care Research (NIHR), Health Research Authority (HRA), and AstraZeneca to delve beneath the surface and discuss the drivers behind the new National Contract Value Review (NCVR) process and its implications for commercial research sponsors. This webinar developed by the NIHR; a panel of industry experts will discuss how the NCVR is transforming study set-up timelines in the UK.

Discover more about the defining factors that enable the UK to foster such system-wide changes and what other countries can learn from the nation’s approach to the evolution of costing and contracting.

The NCVR mission is clear – to expedite the set-up of clinical trials, fortify the UK’s global position in attracting cutting-edge studies, and ensure that patients benefit from access to innovative treatments. But what does this mean for organisations looking to conduct commercial research in the UK?

This conference is being run by NIHR if you have any questions, please contact the event team.